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Association of Hospital Racial Composition and Payer Mix With
Mortality in Acute Coronary Syndrome
Pratyaksh K. Srivastava, MD; Gregg C. Fonarow, MD; Ehete Bahiru, MD; Boback Ziaeian, MD, PhD
Background-—Patient characteristics insufficiently explain disparities in cardiovascular outcomes among hospitalized patients,
suggesting a role for community or hospital-level factors. Here, we evaluate the association of hospital racial composition and
payer mix with all-cause inpatient mortality for patients hospitalized with acute coronary syndrome (ACS).
Methods and Results-—Using the National Inpatient Sample, we identified adult hospitalizations from 2014 with a primary
diagnosis of ACS (n=550 005). We divided National Inpatient Sample hospitals into quartiles based on percent of minority (black,
Hispanic, Asian or Pacific Islander, Native American race/ethnicity) and low-income payer (Medicaid or uninsured) discharges in
2014. We utilized logistic regression to determine whether hospital minority or low-income payer makeup associated with all-cause
inpatient mortality among those admitted for ACS . In adjusted models, ACS patients admitted to hospitals with >12.4% to 25.4%
(Quartile 2), >25.4% to 44.3% (Q3), and >44.3% (Q4) minority discharges experienced a 14% (OR 1.14, 95% CI 1.06–1.23), 13% (OR
1.13, 95% CI 1.04–1.23), and 15% (OR 1.15, 95% CI 1.04–1.26) increased odds of all-cause inpatient mortality compared with
hospitals with ≤12.4% (Q1) minority discharges. ACS patients admitted to hospitals with >18.7% to 25.7% (Q2) and >34.0% (Q4)
low-income payer discharges experienced a 9% (OR 1.09, 1.01–1.17) and 9% (OR 1.09, 1.00–1.19) increased odds of all-cause
inpatient mortality when compared with hospitals with ≤18.7% (Q1) low-income payer discharges.
Conclusions-—Hospital minority and low-income payer makeup positively associate with odds of all-cause inpatient mortality
among patients admitted for acute coronary syndrome. ( J Am Heart Assoc. 2019;8:e012831. DOI: 10.1161/JAHA.119.
012831.)
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P atient race/ethnicity and socioeconomic status signifi-cantly associate with cardiovascular morbidity and
mortality. Black patients have higher rates of fatal coronary
artery disease, are diagnosed with heart failure at an earlier
age, and experience worse cardiovascular outcomes.1–6
Medicaid and uninsured patients are less likely to receive
optimal medical therapy for heart failure and acute coronary
syndrome (ACS), and have higher cardiovascular mortality
compared with patients with private insurance.7–11 When
evaluating health outcomes, disparities in cardiovascular
morbidity and mortality are inadequately explained by
patient-level characteristics such as demographics, race,
regional income, and comorbidities, even after traditional
hospital characteristics are taken into account.12–14 Hospi-
tal racial composition and payer mix represent 2 potentially
important system factors not typically accounted for in
traditional risk-adjusted cardiovascular models. Patients
admitted to safety net hospitals are less likely to receive
optimal goal-directed medical therapy, while patients admit-
ted to hospitals with greater minority populations have
been shown to experience increased cardiovascular mortal-
ity.13,15–18 Prior work assessing the impact of hospital race
and payer mix on cardiovascular outcomes is limited to a
narrow geographic region or the Medicare or Medicaid
population.12 Research suggests that Medicare patients are
a poor surrogate for the general population, and studies of
smaller geographic regions have limited generalizability.19
Given the seemingly important impact of hospital race and
payer makeup on cardiovascular outcomes, and the lack of
studies exploring this relationship in the general population,
we sought to evaluate the association of hospital minority
makeup and low-income payer (Medicaid or uninsured) mix
with all-cause inpatient mortality among patients admitted
for ACS.
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Methods
The National Inpatient Sample (NIS) data set provides hospital
administrative data through the Agency for Healthcare
Research and Quality’s Healthcare Cost and Utilization
Project. For 2014, the NIS included 44 states and the District
of Columbia, and encompassed >96% of the US population.
Patients with all insurances, including those with Medicare
Advantage and the uninsured, are included. NIS methodology
and sampling details are described elsewhere.20 NIS data
used for the analyses below are publicly available. Methods
and materials used to conduct analyses below are available
upon request.
The 2014 NIS consists of 29 751 955 discharges from
4400 hospitals. After exclusion of discharges of nonadults
(<18 years of age), discharges with missing age informa-
tion, discharges from hospitals with <2500 discharges, and
discharges from hospitals with ≥10% missing race or payer
information, 26 107 715 discharges from 2293 hospitals
remained. Of these, 550 005 were admitted with a primary
diagnosis of ACS. This cohort was used for the analyses below
(Figure 1).
NIS hospitals were divided into quartiles based on percent
of minority (black, Hispanic, Asian or Pacific Islander, Native
American race/ethnicity) and low-income payer (Medicaid or
uninsured) discharges in 2014. We used logistic regression to
investigate the association between hospital minority and low-
income payer quartile, and the odds of all-cause inpatient
mortality among those admitted for a primary diagnosis of
ACS. Model 1 was adjusted for age and sex. Model 2 was
adjusted for the covariables in Model 1 plus traditional
hospital characteristics available: teaching status, bed size,
and region. Model 3 was adjusted for the covariables in Model
2 plus patient comorbidities and procedures received before
the hospitalization visit from which data were obtained
(Figure 2). Model 4 was adjusted for the covariables in Model
3 plus for individual-level race and individual-level payer
status. A cubic spline analysis was subsequently conducted to
continuously model the impact of hospital minority makeup
and low payer status on probability of all-cause inpatient
mortality for patients admitted with ACS. Three knots were
used for the spline models. Cubic splines were adjusted for
the covariables in Model 4. Last, we compared rates of
various inpatient procedures across hospital minority and low-
income payer quartiles using a nonparametric Pearson v2 test
of proportions. All statistical analysis was performed using
Stata 15.1 (StataCorp, College Station, TX). Survey-specific
data commands were utilized where applicable. P.K.S. and
B.Z. had full access to the data, and take responsibility for the
integrity of the data analysis. An institutional review board
waiver was obtained for the project.
Results
The final cohort included 550 005 primary ACS discharges
(Figure 1) with a median age (95% CI) of 66.8 (66.7–67.0)
Figure 1. Determination of the final cohort. NIS indicates
National Inpatient Sample.
Clinical Perspective
What Is New?
• In a large, nationwide sample, hospital minority and low-
income payer makeup were both found to positively
associate with odds of all-cause inpatient mortality among
patients admitted with acute coronary syndrome.
• Facilities taking care of larger proportions of minority and
low-income payer patients were found to have lower rates of
invasive cardiovascular procedures, and potentially a sicker
baseline population.
What Are the Clinical Implications?
• Policy changes that provide resources and support to
facilities taking care of large proportions of minority and
low-income payer patients are needed and have the
potential to improve outcomes for those admitted with
acute coronary syndrome.
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years. Thirty-eight percent were female, 10.6% were black,
and 14.5% were low-income payer (Medicaid or Uninsured). In
the cohort, 77.2% had hypertension, 42.3% had diabetes
mellitus, and 17.4% were obese. Five percent of the cohort
died during hospitalization. Full baseline characteristics of the
population are presented in Table 1.
After adjustment, ACS patients admitted to hospitals with
>12.4% to 25.4% (Quartile 2), >25.4% to 44.3% (Q3), and
>44.3% (Q4) minority discharges experienced a 14% (OR 1.14,
95% CI 1.06–1.23), 13% (OR 1.13, 95% CI 1.04–1.23), and
15% (OR 1.15, 95% CI 1.04–1.26) increased odds of all-cause
inpatient mortality compared with hospitals with ≤12.4% (Q1)
minority discharges (Table 2, Model 4). ACS patients admitted
to hospitals with >18.7% to 25.7% (Q2) and >34.0% (Q4) low-
income payer discharges experienced a 9% (OR 1.09, 95% CI
1.01–1.17) and 9% (OR 1.09, 95% CI 1.00–1.19) increased
odds of all-cause inpatient mortality when compared with
hospitals with ≤18.7% (Q1) low-income payer discharges
(Table 3, Model 4). In sensitivity analysis, there were no
interactions observed between sex and hospital minority or
low-income payer quartile.
Adjusted cubic splines (Model 4) continuously modeling
the impact of hospital minority and low-payer makeup on
probability of inpatient death from acute coronary syn-
drome are shown in Figure 3. In the adjusted minority
analysis, hospital minority make up positively associates
with odds of all-cause inpatient mortality from ACS across
all 4 quartiles (Figure 3A). In the adjusted low-payer
analysis, hospital low-payer makeup positively associates
with odds of all-cause inpatient mortality across the first 3
quartiles. Though the slope of the line changes over
quartile 4, the probability of death in quartile 4 still
remains higher than seen in the majority of quartile 1
(Figure 3B).
Among patients admitted for ACS, rates of coronary
angiography and percutaneous coronary intervention
Figure 2. Patient history/comorbidities adjusted for in logistic regression models. CCS indicates clinical
classification software; ICD, International Classification of Diseases.
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significantly differed across hospital minority and low-income
payer quartile (Tables 4 and 5). In general, rates of coronary
angiography and percutaneous coronary intervention were
lower in Q4 compared with Q1–Q3 minority and low-payer
hospitals. ACS patients admitted to hospitals with greater
percentages of minority and low-income payer discharges
were also found to have increased rates of cardiac arrest,
hemodialysis, and mechanical ventilation (Tables 4 and 5).
Discussion
In this cross-sectional study of 550 005 primary ACS
discharges, both hospital minority and hospital low-income
payer makeup positively associated with odds of all-cause
inpatient mortality among patients admitted for ACS.
While prior research demonstrates that minority and low-
income payer patients experience worse cardiovascular out-
comes, there have been limited studies evaluating the impact
of hospital-level minority makeup and payer mix on inpatient
mortality in a large nationwide sample.7–11,18 Here, we
demonstrate that ACS patients admitted to hospitals with
higher proportions of minority and low-income payer dis-
charges have increased all-cause inpatient mortality, even
after adjustment for age, sex, hospital characteristics, patient
comorbidities, individual patient race, and individual patient
payer status.
Table 1. Baseline Characteristics of the Cohort
Variable
Total Adult National Inpatient Sample Primary Acute Coronary Syndrome Diagnosis
n=26 107 715 n=550 005
Age
Age, mean (95% CI), y 57.1 (56.9–57.4) 66.8 (66.7–67.0)
Sex
Women, N (%) 15 301 770 (58.6) 208 945 (38.0)
Race
White, N (%) 17 448 531 (66.8) 408 015 (74.2)
Black, N (%) 3 948 580 (15.1) 58 325 (10.6)
Hispanic, N (%) 2 866 795 (11.0) 42 955 (7.8)
Asian or Pacific Islander, N (%) 670 220 (2.6) 13 405 (2.4)
Native American, N (%) 141 280 (0.5) 2820 (0.5)
Other, N (%) 796 730 (3.1) 17 720 (3.2)
Payer status
Medicare, N (%) 12 033 796 (46.1) 312 255 (56.8)
Medicaid, N (%) 4 767 559 (18.3) 47 525 (8.6)
Private insurance, N (%) 7 247 250 (27.8) 143 580 (26.1)
Uninsured, N (%) 1 282 840 (4.9) 32 210 (5.9)
Other, N (%) 743 825 (2.8) 13 680 (2.5)
Low payer (Medicaid+uninsured), N (%) 6 050 399 (23.2) 79 735 (14.5)
Inpatient mortality
Died during hospitalization, N (%) 580 170 (2.2) 27 275 (5.0)
Comorbidities
Hypertension, N (%) 13 789 521 (52.8) 424 550 (77.2)
Lipid disorder, N (%) 7 928 876 (30.4) 358 090 (65.1)
Diabetes mellitus, N (%) 7 169 490 (27.5) 232 770 (42.3)
Obesity, N (%) 3 734 500 (14.3) 95 465 (17.4)
Tobacco abuse disorder, N (%) 3 977 760 (15.2) 140 595 (25.6)
Coronary artery disease, N (%) 5 510 070 (21.1) 457 685 (83.2)
Chronic kidney disease, N (%) 3 144 225 (12.0) 101 775 (18.5)
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One explanation may be that hospitals with large
proportions of minority and low-income payer patients
lack the resources necessary to provide the invasive
procedures often required for acute cardiovascular care. To
test this hypothesis, we compared rates of invasive cardiac
procedures performed during the patient’s hospitalization
from which data were obtained across different hospital
minority and low-income payer quartiles. We found lower
rates of coronary angiography and percutaneous coronary
intervention in Q4 minority and low-payer hospitals com-
pared with hospitals in earlier quartiles. It should be noted,
however, that is difficult to ascertain why certain hospitals
may be performing more or fewer procedures. While 1
hypothesis may be that hospitals taking care of larger
proportions of lower-paying patients may be under-
resourced, and therefore have lower procedure rates, it
is also possible that hospitals may be inappropriately
performing more or fewer procedures based on a variety of
other factors such as physician decision making or regional
practice patterns.
After additionally adjusting for angiography and percuta-
neous coronary intervention rates, ACS patients admitted to
Q2, Q3, and Q4 minority hospitals still had increased odds of
all-cause inpatient mortality with ORs of 1.13 (95% CI 1.05–
1.22), 1.13 (95% CI 1.04–1.23), and 1.11 (95% CI 1.00–1.22),
respectively, when compared with patients in Q1 minority
hospitals. ACS patients attending Q2 low-payer hospitals also
still had increased rates of all-cause inpatient mortality after
additional adjustment for procedures (OR 1.08, 95% CI 1.01–
1.17).
Part of the residual disparity may be explained by the
baseline severity of patient comorbidities. Minority and
Table 2. Hospital Minority Makeup and Odds of Inpatient Mortality Among Patients Admitted for Acute Coronary Syndrome
Hospital Minority Quartile
Odds of Inpatient Mortality (95% CI)
1 (0–12.4%) 2 (>12.4–25.4%) 3 (>25.4–44.3%) 4 (>44.3%)
N died/N alive (% mortality) 7635/162 505 (4.7%) 7025/132 090 (5.3%) 6665/123 245 (5.4%) 5950/104 675 (5.7%)
Model 1 1 1.17 (1.09–1.26)‡ 1.24 (1.15–1.34)‡ 1.31 (1.22–1.41)‡
Model 2 1 1.14 (1.06–1.23)‡ 1.17 (1.08–1.26)‡ 1.24 (1.15–1.35)‡
Model 3 1 1.14 (1.06–1.23)‡ 1.13 (1.05–1.23)† 1.16 (1.07–1.26)‡
Model 4 1 1.14 (1.06–1.23)‡ 1.13 (1.04–1.23)† 1.15 (1.04–1.26)†
Model 1: adjusted for age and sex. Model 2: adjusted for variables in Model 1 plus for hospital teaching status, hospital bed size, hospital region. Model 3: adjusted for variables in Model 2
plus for history of percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, coronary artery disease, valvulopathy, hypertension, chronic obstructive pulmonary
disease, diabetes mellitus without complications, protein-calorie malnutrition, dementia, lymphoma, solid malignancy, metastatic malignancy, psychiatric disorders, chronic liver disease,
pulmonary heart disease, peptic ulcer disease, human immunodeficiency virus, rheumatoid arthritis, obesity, alcohol use, drug use, hyperlipidemia, smoking, chronic kidney disease. Model
4: adjusted for variables in Model 3 plus individual-level race and individual-level payer status.
†P<0.01.
‡P<0.001.
Table 3. Hospital Low-Income Payer Makeup and Odds of Inpatient Mortality Among Patients Admitted for Acute Coronary
Syndrome
Hospital Low-Income Payer Quartile
Odds of Inpatient Mortality (95% CI)
1 (0–18.7%) 2 (>18.7–25.7%) 3 (>25.7–34.0%) 4 (>34.0%)
N died/N alive (% mortality) 7440/151 230 (4.9%) 7580/144 485 (5.2%) 7230/136 550 (5.3%) 5025/90 250 (5.6%)
Model 1 1 1.13 (1.05–1.21)‡ 1.17 (1.08–1.26)‡ 1.28 (1.18–1.39)‡
Model 2 1 1.11 (1.04–1.19)† 1.13 (1.04–1.22)† 1.22 (1.12–1.32)‡
Model 3 1 1.10 (1.02–1.18)* 1.08 (1.00–1.17) 1.13 (1.04–1.23)†
Model 4 1 1.09 (1.01–1.17)* 1.07 (0.99–1.16) 1.09 (1.00–1.19)*
Model 1: adjusted for age and sex. Model 2: adjusted for variables in Model 1 plus for hospital teaching status, hospital bed size, hospital region. Model 3: adjusted for variables in Model 2
plus for history of percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, coronary artery disease, valvulopathy, hypertension, chronic obstructive pulmonary
disease, diabetes mellitus without complications, protein-calorie malnutrition, dementia, lymphoma, solid malignancy, metastatic malignancy, psychiatric disorders, chronic liver disease,
pulmonary heart disease, peptic ulcer disease, human immunodeficiency virus, rheumatoid arthritis, obesity, alcohol use, drug use, hyperlipidemia, smoking, chronic kidney disease. Model
4: adjusted for variables in Model 3 plus individual-level race and individual-level payer status.
*P<0.05.
†P<0.01.
‡P<0.001.
DOI: 10.1161/JAHA.119.012831 Journal of the American Heart Association 5
Hospital Race Payer Mix in Acute Coronary Syndrome Srivastava et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
low-income payer patients often have more advanced and
more poorly controlled comorbidities because of a variety of
different factors.7,21–24 While models may control for the
presence or absence of a condition, they are unable to fully
account for severity, which may result in unmeasured con-
founding. In both our minority and low-payer analyses, patients
admitted to hospitals with higher proportions of minority and
low-income payer patients were more likely to require
hemodialysis and mechanical ventilation, and were more likely
to have cardiac arrest, potentially suggesting a sicker baseline
population. Furthermore, minority and low-income payer status
likely serves as a proxy for overall socioeconomic status, which
Figure 3. Hospital minority (A) and low-income payer (B) makeup and probability of inpatient mortality for
patients admitted with primary diagnosis of Acute Coronary Syndrome. Cubic Spline Models adjusted for
age, sex, patient race, patient payer status, patient comorbidities, and hospital characteristics (Model 4).
Hospital minority and low-income payer quartiles are designated by dashed purple lines.
Table 4. Procedures Stratified by Hospital Minority Quartile for Patients Admitted With Acute Coronary Syndrome
Variable
Hospital Minority Quartile
P Value*
1 (0–12.4%) 2 (>12.4–25.4%) 3 (>25.4–44.3%) 4 (>44.3%)
n=170 200 n=139 160 n=129 980 n=110 665
Pulmonary artery catheter placement, N (%) 1535 (0.9) 1755 (1.3) 1520 (1.2) 880 (0.8) 0.06
Angiogram, N (%) 121 230 (71.2) 102 180 (73.4) 96 500 (74.2) 74 375 (67.2) <0.001
Percutaneous coronary intervention, N (%) 82 505 (48.5) 70 440 (50.6) 65 220 (50.2) 48 140 (43.5) <0.001
PPM or ICD placement/revision, N (%) 3415 (2.0) 3340 (2.4) 3125 (2.4) 2500 (2.3) 0.03
ECMO, N (%) 11 055 (6.5) 11 830 (8.5) 11 365 (8.7) 8265 (7.5) <0.001
Cardioversion, N (%) 4925 (2.9) 5050 (3.6) 4810 (3.7) 4175 (3.8) <0.001
Cardiac arrest, N (%) 8295 (4.9) 7895 (5.7) 7130 (5.5) 6415 (5.8) <0.001
Hemodialysis, N (%) 3895 (2.3) 4380 (3.1) 4965 (3.8) 6490 (5.9) <0.001
Mechanical ventilation, N (%) 12 590 (7.4) 12 470 (9.0) 12 305 (9.5) 12 040 (10.9) <0.001
Noninvasive ventilation, N (%) 3900 (2.3) 3405 (2.4) 3400 (2.6) 3530 (3.2) 0.001
Blood product transfusion, N (%) 9115 (5.4) 8930 (6.4) 9550 (7.3) 9340 (8.4) <0.001
Thoracentesis, N (%) 1605 (0.9) 1750 (1.3) 1605 (1.2) 1425 (1.3) 0.003
ECMO indicates extracorporeal membrane oxygenation; ICD, implantable cardioverter defibrillator; PPM, permanent pacemaker.
*Categorical variables compared across quartiles using nonparametric Pearson v2 Test of Proportions.
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can contribute to unmeasured confounding through difficult-
to-measure environmental factors.25–28
The remaining association may be explained by a number
of intangible, and often unmeasured, hospital-level factors.
Hospitals with greater numbers of minority and low-income
payer patients may be under-resourced, and therefore may
lack the personnel, communication, and integration necessary
for efficient patient transitions from the Emergency Room to
higher levels of care.29 Hospital culture, engagement in
quality, and the use of protocol-driven therapies may also be
contributing.12 Last, low-income payer hospitals are less likely
to provide guideline-directed medical therapy, and low-income
payer patients are less likely to receive the standard of care
for a wide range of cardiovascular conditions, which may be
contributing further to the observed disparity.8,10,18,30–32
Reimbursement systems that focus solely on quality
outcomes, and not the reasons behind those outcomes,
may unfairly punish hospitals taking care of large proportions
of minority and low-payer patients. As prior research and the
data above demonstrate, poor outcomes in these facilities
may be the result of both hospital quality (less access to
invasive procedures, understaffing, less use of protocol-driven
therapies) and baseline patient health (more severe baseline
comorbidities in segregated environments). Providing financial
support, as opposed to punitive action, to help hire trained
staff, purchase needed equipment, and establish protocol-
driven procedures has the potential to even the playing field,
and improve outcomes for ACS patients admitted to facilities
with large proportions of minority and low-payer patients.33
This study is limited by the design of the NIS, which does not
allow for identification of specific patients, and therefore allows
for 1 patient to potentially contribute multiple discharges over
the course of a year. The NIS relies on administrative collection
of diagnoses, which may limit the accuracy of diagnostic
definitions. The NIS does not provide data on long-term
outcomes for discharges and therefore does not allow for
longitudinal analysis of mortality disparities. Furthermore, the
NIS does not allow for delineation of data by state, which limits
analysis on the influence of state-level policies. Lastly, while
attempts were made to control for patient severity and
comorbidities, the potential for residual and unmeasured
confounding remains.
In conclusion, hospital minority and low-income payer
makeup were found to positively associate with odds of all-
cause inpatient mortality among those admitted with ACS
despite adjusting for age, sex, hospital characteristics, patient
comorbidities, and individual patient race and insurance
status. Policy changes that provide resources and support
to facilities taking care of large proportions of minority and
low-income payer patients are needed, and have the potential
to improve outcomes for those admitted with ACS.
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Table 5. Procedures Stratified by Hospital Low-Income Payer Quartile for Patients Admitted With Acute Coronary Syndrome
Variable
Hospital Low-Payer Quartile
P Value*
1 (0–18.7%) 2 (>18.7–25.7%) 3 (>25.9–34.0%) 4 (>34.0%)
n=158 765 n=152 120 n=143 790 n=95 330
Pulmonary artery catheter placement, N (%) 1480 (0.9) 1620 (1.1) 1735 (1.2) 855 (0.9) 0.40
Angiogram, N (%) 111 455 (70.2) 111 195 (73.1) 105 650 (73.5) 65 985 (69.2) <0.001
Percutaneous coronary intervention, N (%) 75 780 (47.7) 75 790 (49.8) 71 655 (49.8) 43 080 (45.2) <0.001
PPM or ICD placement/revision, N (%) 3535 (2.2) 3480 (2.3) 3170 (2.2) 2195 (2.3) 0.92
ECMO, N (%) 11 645 (7.3) 12 290 (8.1) 11 690 (8.1) 6890 (7.2) 0.15
Cardioversion, N (%) 5115 (3.2) 5275 (3.5) 4940 (3.4) 3630 (3.8) 0.07
Cardiac arrest, N (%) 8040 (5.1) 8560 (5.6) 7730 (5.4) 5405 (5.7) 0.01
Hemodialysis, N (%) 5080 (3.2) 4780 (3.1) 5155 (3.6) 4715 (4.9) <0.001
Mechanical ventilation, N (%) 13 195 (8.3) 12 790 (8.4) 13 025 (9.1) 10 395 (10.9) <0.001
Noninvasive ventilation, N (%) 4125 (2.6) 3545 (2.3) 3630 (2.5) 2935 (3.1) 0.03
Blood product transfusion, N (%) 10 725 (6.8) 9370 (6.2) 9530 (6.6) 7310 (7.7) 0.02
Thoracentesis, N (%) 1735 (1.1) 1700 (1.1) 1715 (1.2) 1235 (1.3) 0.33
ECMO indicates extracorporeal membrane oxygenation; ICD, implantable cardioverter defibrillator; PPM, permanent pacemaker.
*Categorical variables compared across quartiles using nonparametric Pearson v2 Test of Proportions.
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